Warby Parker Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Warby Parker Inc. (WRBY) reported Net Income (Loss) Available to Common Stockholders, Diluted of $4.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-06
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $4.64M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $3.18M, a 8.50% decline year-over-year.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$5.95M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $5.87M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for fiscal 2025 was $1.64M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for fiscal 2024 was -$20.39M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$63.20M.
- Warby Parker Inc. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$110.39M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.64M 10-Q · filed 2026-08-06 | $7.82M 10-Q · filed 2026-08-06 | $1.87M derived: sum of 3 quarters · filed 2026-08-06 | $7.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.18M 10-Q · filed 2026-05-07 | -$2.78M derived: sum of 2 quarters · filed 2026-05-07 | $3.10M derived: sum of 3 quarters · filed 2026-05-07 | $1.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$79.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.83M derived: sum of 3 quarters · filed 2026-08-06 | $1.64M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.87M 10-Q · filed 2025-11-06 | $4.12M derived: sum of 2 quarters · filed 2026-08-06 | $7.59M 10-Q · filed 2025-11-06 | $717.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.75M 10-Q · filed 2026-08-06 | $1.72M 10-Q · filed 2026-08-06 | -$5.16M derived: sum of 3 quarters · filed 2026-08-06 | -$9.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.47M 10-Q · filed 2026-05-07 | -$3.40M derived: sum of 2 quarters · filed 2026-05-07 | -$7.48M derived: sum of 3 quarters · filed 2026-05-07 | -$14.24M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.95M derived: sum of 2 quarters · filed 2026-02-26 | -$17.71M derived: sum of 3 quarters · filed 2026-02-26 | -$20.39M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$4.07M 10-Q · filed 2025-11-06 | -$10.83M derived: sum of 2 quarters · filed 2025-11-06 | -$13.51M 10-Q · filed 2025-11-06 | -$32.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$6.76M 10-Q · filed 2025-08-08 | -$9.44M 10-Q · filed 2025-08-08 | -$28.49M derived: sum of 3 quarters · filed 2026-02-26 | -$45.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$2.68M 10-Q · filed 2025-05-08 | -$21.73M derived: sum of 2 quarters · filed 2026-02-26 | -$39.14M derived: sum of 3 quarters · filed 2026-02-26 | -$55.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$36.46M derived: sum of 2 quarters · filed 2026-02-26 | -$52.38M derived: sum of 3 quarters · filed 2026-02-26 | -$63.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$17.41M 10-Q · filed 2024-11-07 | -$33.34M derived: sum of 2 quarters · filed 2024-11-07 | -$44.15M 10-Q · filed 2024-11-07 | -$64.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$15.93M 10-Q · filed 2024-08-08 | -$26.74M 10-Q · filed 2024-08-08 | -$46.99M derived: sum of 3 quarters · filed 2025-02-27 | -$70.83M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$10.81M 10-Q · filed 2024-05-09 | -$31.06M derived: sum of 2 quarters · filed 2025-02-27 | -$54.91M derived: sum of 3 quarters · filed 2025-02-27 | -$87.07M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$20.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$44.09M derived: sum of 2 quarters · filed 2025-02-27 | -$76.26M derived: sum of 3 quarters · filed 2025-02-27 | -$110.39M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$23.84M 10-Q · filed 2023-11-08 | -$56.01M derived: sum of 2 quarters · filed 2023-11-08 | -$90.14M 10-Q · filed 2023-11-08 | -$136.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$32.17M 10-Q · filed 2023-08-09 | -$66.30M 10-Q · filed 2023-08-09 | -$112.20M derived: sum of 3 quarters · filed 2024-02-29 | -$203.28M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$34.13M 10-Q · filed 2023-05-09 | -$80.04M derived: sum of 2 quarters · filed 2024-02-29 | -$171.11M derived: sum of 3 quarters · filed 2024-02-29 | -$189.94M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$45.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$136.98M derived: sum of 2 quarters · filed 2024-02-29 | -$155.81M derived: sum of 3 quarters · filed 2024-02-29 | -$157.41M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$91.07M 10-Q · filed 2022-11-10 | -$109.90M derived: sum of 2 quarters · filed 2022-11-10 | -$111.50M 10-Q · filed 2022-11-10 | -$115.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$18.83M 10-Q · filed 2022-08-11 | -$20.43M 10-Q · filed 2022-08-11 | -$24.73M derived: sum of 3 quarters · filed 2023-02-28 | -$66.34M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.60M 10-Q · filed 2022-05-16 | -$5.90M derived: sum of 2 quarters · filed 2023-02-28 | -$47.51M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$45.91M derived: sum of 2 quarters · filed 2023-02-28 | -$55.92M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$41.61M 10-Q · filed 2021-11-12 | -$51.62M 10-Q · filed 2021-11-12 | ||
| 2019-12-31 | -$57.54M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |